Listen on the go
CORRECT!
Next question
touchRESPIRATORY touchRESPIRATORY
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:

    • Bronchiectasis

    Bronchiectasis Content

    Bronchiectasis
    Brensocatib: An Anti-neutrophil Elastase Drug With Potential in the Management of Bronchiectasis
    Simon Bowler

    touchREVIEWS in Respiratory & Pulmonary Diseases. 2022;7(2):34–5 DOI: https://doi.org/10.17925/USRPD.2022.7.2.34

    Judith Durham (of The Seekers fame) died in August this year from bronchiectasis – a timely reminder of the morbidity and mortality associated with this disease of chronic airway inflammation and damage and a tribute to Durham’s personal and professional resilience.1 The measles that initiated Durham’s airway damage is mercifully now rare (although bronchiectasis can develop […]

    Respiratory Infection, Airway Diseases, Bronchiectasis, Chronic Cough
    Watch Time: 33 mins
    touchIN CONVERSATION
    Management of patients with NTM-LD: Improving adherence for optimal outcomes
    CE/CME ACCREDITED Prof. Doreen Addrizzo-Harris, Dr Ashwin Basavaraj

    Watch expert pulmonologists discuss how to optimize the diagnosis and management of patients with NTM-LD

    Learning objectives
    Learning Objectives
    • Appraise strategies to reduce time to diagnosis for patients with NTM-LD
    • Utilize guideline recommendations when setting individualized treatment goals for patients with NTM-LD
    • Apply strategies to manage adverse events for improved outcomes and adherence in patients with NTM-LD
    Bronchiectasis, Respiratory Infection, Chronic Cough
    Watch Time: 36 mins
    touchMDT
    The patient pathway to diagnosis for non-cystic fibrosis bronchiectasis
    CE/CME ACCREDITED Prof. James Chalmers, Prof. Mary Salvatore, Prof. Barbara Yawn and Ms Marta Almagro Translations available:

    MDT specialists and a patient with non-cystic fibrosis (non-CF) bronchiectasis discuss the pathophysiology, comorbidities and the pathway to diagnosis

    Learning objectives
    Learning Objectives
    • Describe the pathophysiology and comorbidities of non-CF bronchiectasis
    • Appraise the clinical presentations of non-CF bronchiectasis
    • Analyse the methodologies to diagnose non-CF bronchiectasis
    Bronchiectasis
    Developed by Touch
    Stefano Aliberti: What to Expect from the 3rd European Bronchiectasis Workshop
    Watch Time: 8 mins

    touchRESPIRATORY caught up with World Bronchiectasis & NTM Conference organising committee member, Prof. Stefano Aliberti (Humanitas University, Milan and IRCCS Humanitas Research Hospital, Lombardia, Italy) to learn more around the upcoming conference taking place in Milan in 2023 and about Prof. Aliberti’s bid to become the European Respiratory Society Vice President. The 5th World Bronchiectasis […]

    Bronchiectasis
    Developed by Touch
    Stefano Aliberti: Take Home Messages and the Patient Voice at the World Bronchiectasis & NTM Conference
    Watch Time: 7 mins

    It was a pleasure to talk with World Bronchiectasis & NTM Conference organising committee member, Prof. Stefano Aliberti (Humanitas University, Milan and IRCCS Humanitas Research Hospital, Lombardia, Italy) to discuss the experience of meeting in person at this year’s conference, the key take home messages of the roundtable on approaches to bronchiectasis and the importance […]

    Bronchiectasis
    Developed by Touch
    Francesco Blasi: Highlights from the World Bronchiectasis & NTM Conference
    Watch Time: 8 mins

    touchRESPIRATORY were delighted to catch up with World Bronchiectasis & NTM Conference organising committee member, Prof. Francesco Blasi (University of Milan and IRCCS Fondazione Cà Granda Ospedale Maggiore, Milan, Italy) to discuss the take home messages from this year’s conference, the importance of young researchers in the Bronchiectasis & NTM community and what to look forward […]

    Bronchiectasis, Respiratory Infection, Chronic Cough
    Watch Time: 32 mins
    touchPANEL DISCUSSION
    Current and future best practice for the management of non-cystic fibrosis bronchiectasis
    CE/CME ACCREDITED Dr Charles Daley, Prof. Stefano Aliberti and Dr Anne O’Donnell Translations available:

    Experts discuss best practice management options for patients with non-cystic fibrosis bronchiectasis.

    Learning objectives
    Learning Objectives
    • Review the incidence, causes and risk factors for non-cystic fibrosis bronchiectasis
    • Discuss eradication protocols for infection in patients with non-cystic fibrosis bronchiectasis
    • Evaluate available and emerging pharmacotherapeutic treatments for non-cystic fibrosis bronchiectasis
    Bronchiectasis
    European Respiratory Society Guidelines for the Management of Bronchiectasis in Children and Adolescents
    Andrew Bush

    touchREVIEWS in Respiratory & Pulmonary Diseases. 2021;6(1):8–9 DOI: https://doi.org/10.17925/USPRD.2021.6.1.8

    Bronchiectasis is a chronic pulmonary disorder characterized by permanent bronchial dilatation, which in some children may be reversible, and airway inflammation, and by cough and sputum production, as well as recurrent respiratory tract infections.1 Bronchiectasis is associated with poor quality of life for the child/adolescent and their parents, recurrent exacerbations and high cost to healthcare systems.2 […]

    Respiratory Infection, Airway Diseases, Bronchiectasis
    Watch Time: 37 mins
    touchEXPERT OPINIONS
    New guideline-based strategies for improving outcomes in patients with NTM-LD
    CE/CME ACCREDITED Dr Juzar Ali, Dr Doreen Addrizzo-Harris, Dr Kevin Winthrop

    Watch leading experts provide advice on how clinicians should manage their patients with NTM-LD within the context of recently updated guidelines.

    Learning objectives
    Learning Objectives
    • Identify the clinical presentations associated with NTM-LD which can help reduce time to diagnosis and initiation of treatment
    • Apply guideline-based treatment options to set individualized treatment goals in collaboration with patients with NTM-LD
    • Evaluate strategies to improve adherence and manage adverse events in patients with NTM-LD
    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72